Drug Could Prolong Lives of Cancer Patients

Tools

By Alabama News Network

The drug erlotinib may help prolong the lives of patients with cervical cancer.

In a small trial, researchers gave 36 patients the drugs combined with chemo-radiation.

After three years, 80 percent were still alive and 73 percent had no disease progression. Researchers say larger studies are needed.  

What's Trending

This content requires the latest Adobe Flash Player and a browser with JavaScript enabled. Click here for a free download of the latest Adobe Flash Player.

Hot Video From AP

AP Video